{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T10:44:26Z","timestamp":1790765066154,"version":"4.1.0"},"reference-count":56,"publisher":"American Society of Hematology","issue":"10","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2019,3,7]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Female Hodgkin lymphoma (HL) patients treated with chest radiotherapy (RT) have a very high risk of breast cancer. The contribution of genetic factors to this risk is unclear. We therefore examined 211\u2009155 germline single-nucleotide polymorphisms (SNPs) for gene-radiation interaction on breast cancer risk in a case-only analysis including 327 breast cancer patients after chest RT for HL and 4671 first primary breast cancer patients. Nine SNPs showed statistically significant interaction with RT on breast cancer risk (false discovery rate, &amp;lt;20%), of which 1 SNP in the PVT1 oncogene attained the Bonferroni threshold for statistical significance. A polygenic risk score (PRS) composed of these SNPs (RT-interaction-PRS) and a previously published breast cancer PRS (BC-PRS) derived in the general population were evaluated in a case-control analysis comprising the 327 chest-irradiated HL patients with breast cancer and 491 chest-irradiated HL patients without breast cancer. Patients in the highest tertile of the RT-interaction-PRS had a 1.6-fold higher breast cancer risk than those in the lowest tertile. Remarkably, we observed a fourfold increased RT-induced breast cancer risk in the highest compared with the lowest decile of the BC-PRS. On a continuous scale, breast cancer risk increased 1.4-fold per standard deviation of the BC-PRS, similar to the effect size found in the general population. This study demonstrates that genetic factors influence breast cancer risk after chest RT for HL. Given the high absolute breast cancer risk in radiation-exposed women, these results can have important implications for the management of current HL survivors and future patients.<\/jats:p>","DOI":"10.1182\/blood-2018-07-862607","type":"journal-article","created":{"date-parts":[[2018,12,21]],"date-time":"2018-12-21T02:35:36Z","timestamp":1545359736000},"page":"1130-1139","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":37,"title":["Genetic susceptibility to radiation-induced breast cancer after Hodgkin lymphoma"],"prefix":"10.1182","volume":"133","author":[{"given":"Annemieke W. J.","family":"Opstal-van Winden","sequence":"first","affiliation":[{"name":"Department of Epidemiology and Biostatistics,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1126-4776","authenticated-orcid":false,"given":"Hugoline G.","family":"de Haan","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Biostatistics,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Hauptmann","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Biostatistics,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2228-429X","authenticated-orcid":false,"given":"Marjanka K.","family":"Schmidt","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Biostatistics,"},{"name":"Division of Molecular Pathology,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annegien","family":"Broeks","sequence":"additional","affiliation":[{"name":"Division of Molecular Pathology, Core Facility Molecular Pathology and Biobanking, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola S.","family":"Russell","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile P. M.","family":"Janus","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Augustinus D. G.","family":"Krol","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Leiden University Medical Center, Leiden, The Netherlands;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederieke H.","family":"van der Baan","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Biostatistics,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9197-7068","authenticated-orcid":false,"given":"Marie L.","family":"De Bruin","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Biostatistics,"},{"name":"Copenhagen Centre for Regulatory Science (CORS), University of Copenhagen, Copenhagen, Denmark;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna M.","family":"van Eggermond","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Biostatistics,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4591-1214","authenticated-orcid":false,"given":"Joe","family":"Dennis","sequence":"additional","affiliation":[{"name":"Center for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoda","family":"Anton-Culver","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, University of California Irvine, Irvine, CA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher A.","family":"Haiman","sequence":"additional","affiliation":[{"name":"Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elinor J.","family":"Sawyer","sequence":"additional","affiliation":[{"name":"Innovation Hub, Guy\u2019s Cancer Centre, King\u2019s College London, London, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Cox","sequence":"additional","affiliation":[{"name":"Sheffield Cancer Research, Department of Oncology, University of Sheffield, Sheffield, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Devilee","sequence":"additional","affiliation":[{"name":"Department of Pathology and"},{"name":"Department of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maartje J.","family":"Hooning","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, The Netherlands;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian","family":"Peto","sequence":"additional","affiliation":[{"name":"Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fergus J.","family":"Couch","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8494-732X","authenticated-orcid":false,"given":"Paul","family":"Pharoah","sequence":"additional","affiliation":[{"name":"Centre for Cancer Genetic Epidemiology, Department of Oncology, and"},{"name":"Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick","family":"Orr","sequence":"additional","affiliation":[{"name":"The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas F.","family":"Easton","sequence":"additional","affiliation":[{"name":"Center for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom;"},{"name":"Centre for Cancer Genetic Epidemiology, Department of Oncology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berthe M. P.","family":"Aleman","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise C.","family":"Strong","sequence":"additional","affiliation":[{"name":"MD Anderson Cancer Center, Houston, TX;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Smita","family":"Bhatia","sequence":"additional","affiliation":[{"name":"Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham, Birmingham, AL;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosie","family":"Cooke","sequence":"additional","affiliation":[{"name":"Division of Genetics and Epidemiology, The Institute of Cancer Research, London, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie L.","family":"Robison","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Cancer Control, St. Jude Children\u2019s Research Hospital, Memphis, TN; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony J.","family":"Swerdlow","sequence":"additional","affiliation":[{"name":"Division of Genetics and Epidemiology, The Institute of Cancer Research, London, United Kingdom;"},{"name":"Division of Breast Cancer Research, The Institute of Cancer Research, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flora E.","family":"van Leeuwen","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Biostatistics,"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"6","key":"2020021109084164800_B1","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1002\/(SICI)1097-0142(19970315)79:6<1203::AID-CNCR20>3.0.CO;2-2","article-title":"High risk of breast carcinoma after irradiation of young women with Hodgkin\u2019s disease","volume":"79","author":"Aisenberg","year":"1997","journal-title":"Cancer"},{"issue":"23","key":"2020021109084164800_B2","doi-asserted-by":"crossref","first-page":"4386","DOI":"10.1200\/JCO.2003.11.059","article-title":"High risk of subsequent neoplasms continues with extended follow-up of childhood Hodgkin\u2019s disease: report from the Late Effects Study Group","volume":"21","author":"Bhatia","year":"2003","journal-title":"J Clin Oncol"},{"issue":"26","key":"2020021109084164800_B3","doi-asserted-by":"crossref","first-page":"4239","DOI":"10.1200\/JCO.2008.19.9174","article-title":"Breast cancer risk in female survivors of Hodgkin\u2019s lymphoma: lower risk after smaller radiation volumes","volume":"27","author":"De Bruin","year":"2009","journal-title":"J Clin Oncol"},{"issue":"12","key":"2020021109084164800_B4","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1200\/JCO.2006.09.0936","article-title":"Long-term solid cancer risk among 5-year survivors of Hodgkin\u2019s lymphoma","volume":"25","author":"Hodgson","year":"2007","journal-title":"J Clin Oncol"},{"issue":"21","key":"2020021109084164800_B5","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1200\/JCO.2013.54.4601","article-title":"Breast cancer after chest radiation therapy for childhood cancer","volume":"32","author":"Moskowitz","year":"2014","journal-title":"J Clin Oncol"},{"issue":"26","key":"2020021109084164800_B6","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1056\/NEJMoa1505949","article-title":"Second cancer risk up to 40 years after treatment for Hodgkin\u2019s lymphoma","volume":"373","author":"Schaapveld","year":"2015","journal-title":"N Engl J Med"},{"issue":"19","key":"2020021109084164800_B7","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1093\/jnci\/dji290","article-title":"Cumulative absolute breast cancer risk for young women treated for Hodgkin lymphoma","volume":"97","author":"Travis","year":"2005","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"2020021109084164800_B8","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1200\/JCO.2000.18.3.487","article-title":"Long-term risk of second malignancy in survivors of Hodgkin\u2019s disease treated during adolescence or young adulthood","volume":"18","author":"van Leeuwen","year":"2000","journal-title":"J Clin Oncol"},{"issue":"1","key":"2020021109084164800_B9","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1093\/jnci\/85.1.25","article-title":"Breast cancer after treatment of Hodgkin\u2019s disease","volume":"85","author":"Hancock","year":"1993","journal-title":"J Natl Cancer Inst"},{"issue":"22","key":"2020021109084164800_B10","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1200\/JCO.2011.38.8835","article-title":"Breast cancer risk after supradiaphragmatic radiotherapy for Hodgkin\u2019s lymphoma in England and Wales: a national cohort study","volume":"30","author":"Swerdlow","year":"2012","journal-title":"J Clin Oncol"},{"issue":"6","key":"2020021109084164800_B11","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1182\/blood-2002-02-0634","article-title":"Second malignancy after Hodgkin disease treated with radiation therapy with or without chemotherapy: long-term risks and risk factors","volume":"100","author":"Ng","year":"2002","journal-title":"Blood"},{"issue":"23","key":"2020021109084164800_B12","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1001\/jama.2017.7112","article-title":"Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers","volume":"317","author":"Kuchenbaecker","year":"2017","journal-title":"JAMA"},{"issue":"4","key":"2020021109084164800_B13","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.ijrobp.2017.07.016","article-title":"Breast cancer risk after radiation therapy for hodgkin lymphoma: influence of gonadal hormone exposure","volume":"99","author":"Krul","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"2020021109084164800_B14","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1080\/095530000138367","article-title":"Increased risk of breast cancer following irradiation for Hodgkin\u2019s disease is not a result of ATM germline mutations","volume":"76","author":"Broeks","year":"2000","journal-title":"Int J Radiat Biol"},{"issue":"2","key":"2020021109084164800_B15","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S0360-3016(00)01481-4","article-title":"Breast cancer after mantle irradiation for Hodgkin\u2019s disease: correlation of clinical, pathologic, and molecular features including loss of heterozygosity at BRCA1 and BRCA2","volume":"49","author":"Gaffney","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"24","key":"2020021109084164800_B16","doi-asserted-by":"crossref","first-page":"4505","DOI":"10.1200\/JCO.2003.12.042","article-title":"TP53, BRCA1, and BRCA2 tumor suppressor genes are not commonly mutated in survivors of Hodgkin\u2019s disease with second primary neoplasms","volume":"21","author":"Nichols","year":"2003","journal-title":"J Clin Oncol"},{"issue":"4","key":"2020021109084164800_B17","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1200\/JCO.1999.17.4.1259","article-title":"Heterozygous germline ATM mutations do not contribute to radiation-associated malignancies after Hodgkin\u2019s disease","volume":"17","author":"Nichols","year":"1999","journal-title":"J Clin Oncol"},{"issue":"8","key":"2020021109084164800_B18","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1158\/1055-9965.EPI-08-0300","article-title":"Breast cancer risk polymorphisms and interaction with ionizing radiation among U.S. radiologic technologists","volume":"17","author":"Bhatti","year":"2008","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"2","key":"2020021109084164800_B19","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1667\/RR1985.1","article-title":"Novel breast cancer risk alleles and interaction with ionizing radiation among U.S. radiologic technologists","volume":"173","author":"Bhatti","year":"2010","journal-title":"Radiat Res"},{"issue":"1","key":"2020021109084164800_B20","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/ijc.23066","article-title":"Polymorphisms in DNA repair genes, ionizing radiation exposure and risk of breast cancer in U.S. Radiologic technologists","volume":"122","author":"Bhatti","year":"2008","journal-title":"Int J Cancer"},{"issue":"11","key":"2020021109084164800_B21","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1002\/ijc.23779","article-title":"Nucleotide excision repair polymorphisms may modify ionizing radiation-related breast cancer risk in US radiologic technologists","volume":"123","author":"Rajaraman","year":"2008","journal-title":"Int J Cancer"},{"issue":"11","key":"2020021109084164800_B22","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1007\/s10552-010-9613-7","article-title":"Polymorphisms in oxidative stress and inflammation pathway genes, low-dose ionizing radiation, and the risk of breast cancer among US radiologic technologists","volume":"21","author":"Schonfeld","year":"2010","journal-title":"Cancer Causes Control"},{"issue":"1","key":"2020021109084164800_B23","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s10549-009-0307-3","article-title":"Polymorphisms in estrogen biosynthesis and metabolism-related genes, ionizing radiation exposure, and risk of breast cancer among US radiologic technologists","volume":"118","author":"Sigurdson","year":"2009","journal-title":"Breast Cancer Res Treat"},{"issue":"10","key":"2020021109084164800_B24","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1158\/1055-9965.EPI-07-0282","article-title":"Polymorphisms in apoptosis- and proliferation-related genes, ionizing radiation exposure, and risk of breast cancer among U.S. Radiologic Technologists","volume":"16","author":"Sigurdson","year":"2007","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"15","key":"2020021109084164800_B25","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1016\/j.ejca.2007.07.011","article-title":"Ageing or cancer: a review on the role of caretakers and gatekeepers","volume":"43","author":"van Heemst","year":"2007","journal-title":"Eur J Cancer"},{"issue":"6","key":"2020021109084164800_B26","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/sj.bjc.6602784","article-title":"Array comparative genomic hybridisation (aCGH) analysis of premenopausal breast cancers from a nuclear fallout area and matched cases from western New York","volume":"93","author":"Varma","year":"2005","journal-title":"Br J Cancer"},{"issue":"8","key":"2020021109084164800_B27","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/nm.2407","article-title":"Variants at 6q21 implicate PRDM1 in the etiology of therapy-induced second malignancies after Hodgkin\u2019s lymphoma","volume":"17","author":"Best","year":"2011","journal-title":"Nat Med"},{"issue":"11","key":"2020021109084164800_B28","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djx058","article-title":"Genome-wide association study to identify susceptibility loci that modify radiation-related risk for breast cancer after childhood cancer","volume":"109","author":"Morton","year":"2017","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"2020021109084164800_B29","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1182\/blood-2011-10-383380","article-title":"FGFR2 genotype and risk of radiation-associated breast cancer in Hodgkin lymphoma","volume":"119","author":"Ma","year":"2012","journal-title":"Blood"},{"issue":"5","key":"2020021109084164800_B30","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djv036","article-title":"Prediction of breast cancer risk based on profiling with common genetic variants","volume":"107","author":"Mavaddat","year":"2015","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"2020021109084164800_B31","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/sim.4780130206","article-title":"Non-hierarchical logistic models and case-only designs for assessing susceptibility in population-based case-control studies","volume":"13","author":"Piegorsch","year":"1994","journal-title":"Stat Med"},{"issue":"11","key":"2020021109084164800_B32","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1038\/bjc.2013.219","article-title":"Breast cancer risk following Hodgkin lymphoma radiotherapy in relation to menstrual and reproductive factors","volume":"108","author":"Cooke","year":"2013","journal-title":"Br J Cancer"},{"issue":"24","key":"2020021109084164800_B33","doi-asserted-by":"crossref","first-page":"3901","DOI":"10.1200\/JCO.2008.20.7738","article-title":"Radiation dose and breast cancer risk in the childhood cancer survivor study","volume":"27","author":"Inskip","year":"2009","journal-title":"J Clin Oncol"},{"issue":"13","key":"2020021109084164800_B34","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1093\/jnci\/95.13.971","article-title":"Roles of radiation dose, chemotherapy, and hormonal factors in breast cancer following Hodgkin\u2019s disease","volume":"95","author":"van Leeuwen","year":"2003","journal-title":"J Natl Cancer Inst"},{"issue":"8","key":"2020021109084164800_B35","doi-asserted-by":"crossref","first-page":"590","DOI":"10.7326\/0003-4819-141-8-200410190-00006","article-title":"Breast cancer after childhood cancer: a report from the Childhood Cancer Survivor Study","volume":"141","author":"Kenney","year":"2004","journal-title":"Ann Intern Med"},{"key":"2020021109084164800_B36","doi-asserted-by":"crossref","DOI":"10.1038\/ng.2563","article-title":"Large-scale genotyping identifies 41 new loci associated with breast cancer risk","volume-title":"Nat Genet","author":"Michailidou","year":"2013"},{"issue":"1","key":"2020021109084164800_B37","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J R Stat Soc B"},{"issue":"7571","key":"2020021109084164800_B38","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/nature15393","article-title":"A global reference for human genetic variation","volume":"526","author":"Auton","year":"2015","journal-title":"Nature"},{"issue":"3","key":"2020021109084164800_B39","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s10549-016-3897-6","article-title":"Polygenic risk score is associated with increased disease risk in 52 Finnish breast cancer families","volume":"158","author":"Muranen","year":"2016","journal-title":"Breast Cancer Res Treat"},{"issue":"13","key":"2020021109084164800_B40","doi-asserted-by":"crossref","first-page":"e621","DOI":"10.1016\/S1470-2045(13)70303-6","article-title":"Recommendations for breast cancer surveillance for female survivors of childhood, adolescent, and young adult cancer given chest radiation: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group","volume":"14","author":"Mulder","year":"2013","journal-title":"Lancet Oncol"},{"issue":"7","key":"2020021109084164800_B41","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djw302","article-title":"Evaluation of polygenic risk scores for breast and ovarian cancer risk prediction in BRCA1 and BRCA2 mutation carriers","volume":"109","author":"Kuchenbaecker","year":"2017","journal-title":"J Natl Cancer Inst"},{"issue":"7678","key":"2020021109084164800_B42","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/nature24284","article-title":"Association analysis identifies 65 new breast cancer risk loci","volume":"551","author":"Michailidou","year":"2017","journal-title":"Nature"},{"issue":"12","key":"2020021109084164800_B43","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1038\/ng.3785","article-title":"Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer","volume":"49","author":"Milne","year":"2017","journal-title":"Nat Genet"},{"issue":"7","key":"2020021109084164800_B44","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1038\/sj.bjc.6605877","article-title":"Risk of breast cancer according to clinicopathologic features among long-term survivors of Hodgkin\u2019s lymphoma treated with radiotherapy","volume":"103","author":"Dores","year":"2010","journal-title":"Br J Cancer"},{"issue":"4","key":"2020021109084164800_B45","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1093\/annonc\/mdu017","article-title":"Histologic subtypes of breast cancer following radiotherapy for Hodgkin lymphoma","volume":"25","author":"Horst","year":"2014","journal-title":"Ann Oncol"},{"issue":"34","key":"2020021109084164800_B46","doi-asserted-by":"crossref","first-page":"5088","DOI":"10.1200\/JCO.2010.29.5683","article-title":"Long-term survival among patients with Hodgkin\u2019s lymphoma who developed breast cancer: a population-based study","volume":"28","author":"Milano","year":"2010","journal-title":"J Clin Oncol"},{"issue":"3","key":"2020021109084164800_B47","doi-asserted-by":"crossref","first-page":"e1003348","DOI":"10.1371\/journal.pgen.1003348","article-title":"Power and predictive accuracy of polygenic risk scores [published correction appears in PLoS Genet. 2013;9(4)]","volume":"9","author":"Dudbridge","year":"2013","journal-title":"PLoS Genet"},{"issue":"7256","key":"2020021109084164800_B48","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/nature08185","article-title":"Common polygenic variation contributes to risk of schizophrenia and bipolar disorder","volume":"460","author":"Purcell","year":"2009","journal-title":"Nature"},{"key":"2020021109084164800_B49","first-page":"573","article-title":"Genetic and molecular epidemiology","volume-title":"Modern Epidemiology","author":"Khoury","year":"2008","edition":"3rd ed"},{"issue":"3","key":"2020021109084164800_B50","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1182\/blood-2011-03-339630","article-title":"Multiple Hodgkin lymphoma-associated loci within the HLA region at chromosome 6p21.3","volume":"118","author":"Moutsianas","year":"2011","journal-title":"Blood"},{"issue":"4","key":"2020021109084164800_B51","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1074\/jbc.M111.322875","article-title":"p53-dependent induction of PVT1 and miR-1204","volume":"287","author":"Barsotti","year":"2012","journal-title":"J Biol Chem"},{"issue":"2","key":"2020021109084164800_B52","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1158\/1541-7786.MCR-07-0105","article-title":"The identification of microRNAs in a genomically unstable region of human chromosome 8q24","volume":"6","author":"Huppi","year":"2008","journal-title":"Mol Cancer Res"},{"issue":"12","key":"2020021109084164800_B53","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1038\/ng.696","article-title":"A genome-wide association study of Hodgkin\u2019s lymphoma identifies new susceptibility loci at 2p16.1 (REL), 8q24.21 and 10p14 (GATA3)","volume":"42","author":"Enciso-Mora","year":"2010","journal-title":"Nat Genet"},{"issue":"6","key":"2020021109084164800_B54","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1002\/ijc.30150","article-title":"Fine-scale mapping of 8q24 locus identifies multiple independent risk variants for breast cancer","volume":"139","author":"Shi","year":"2016","journal-title":"Int J Cancer"},{"issue":"3","key":"2020021109084164800_B55","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1667\/RR14891.1","article-title":"Radiation-induced long noncoding RNAs in a mouse model after whole-body irradiation","volume":"189","author":"Aryankalayil","year":"2018","journal-title":"Radiat Res"},{"issue":"2","key":"2020021109084164800_B56","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1093\/ije\/dyx242","article-title":"Joint associations of a polygenic risk score and environmental risk factors for breast cancer in the Breast Cancer Association Consortium","volume":"47","author":"Rudolph","year":"2018","journal-title":"Int J Epidemiol"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/133\/10\/1130\/1556879\/blood862607.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/133\/10\/1130\/1556879\/blood862607.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,13]],"date-time":"2024-07-13T14:58:53Z","timestamp":1720882733000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/133\/10\/1130\/272741\/Genetic-susceptibility-to-radiationinduced-breast"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,7]]},"references-count":56,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2019,3,7]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2018-07-862607","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,7]]}}}